TriaGen Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$293K Buy
+244
New +$249K 0.07% 158
2026
Q1
Sell
-498
Closed -$535K 189
2025
Q4
$535K Buy
+498
New +$476K 0.14% 116
2025
Q1
Sell
-362
Closed -$279K 182
2024
Q4
$279K Sell
362
-700
-66% -$580K 0.09% 145
2024
Q3
$941K Buy
1,062
+298
+39% +$268K 0.32% 73
2024
Q2
$692K Buy
764
+1
+0.1% +$800 0.27% 84
2024
Q1
$594K Sell
763
-9
-1% -$6.41K 0.25% 87
2023
Q4
$450K Sell
772
-1,262
-62% -$737K 0.21% 96
2023
Q3
$1.09M Buy
2,034
+1,332
+190% +$686K 0.56% 57
2023
Q2
$329K Buy
+702
New +$294K 0.15% 123

Other funds holding LLY

TriaGen Wealth Management's LLY Position: Q2 2026 in Review

TriaGen Wealth Management opened a new position in Eli Lilly (LLY) in Q2 2026: 244 shares worth $293K. The stake represents 0.07% of the portfolio and ranks #158 among its holdings. This is a return to the name: TriaGen Wealth Management previously reported a position in LLY as recently as Q4 2025.

TriaGen Wealth Management first reported a position in LLY in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.09M in Q3 2023. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TriaGen Wealth Management held 244 shares of Eli Lilly worth $293K as of Q2 2026.
  • Eli Lilly was a new TriaGen Wealth Management position in Q2 2026.
  • Eli Lilly made up 0.07% of TriaGen Wealth Management's portfolio in Q2 2026, its #158 holding.
  • TriaGen Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 9 quarters since.
  • TriaGen Wealth Management's Eli Lilly position peaked at $1.09M in Q3 2023.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TriaGen Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.